Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

107.75
-1.8500-1.69%
Post-market: 107.860.1100+0.10%16:43 EDT
Volume:885.51K
Turnover:96.15M
Market Cap:6.26B
PE:-32.83
High:110.13
Open:108.51
Low:107.31
Close:109.60
52wk High:130.23
52wk Low:73.16
Shares:58.08M
Float Shares:55.40M
Volume Ratio:1.02
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-5.80%
PB:9.54
PE(LYR):-32.83

Loading ...

Glaukos Corp - Idose Tr Shows Favorable Long-Term Corneal Safety Profile

THOMSON REUTERS
·
Jan 28

Glaukos Corp - Idose Tr Second Administration Safe and Well-Tolerated

THOMSON REUTERS
·
Jan 28

Glaukos Announces US FDA Approval of Nda Supplement Allowing for Re-Administration of Idose® Tr

THOMSON REUTERS
·
Jan 28

Glaukos (GKOS) Receives a Buy from BTIG

TIPRANKS
·
Jan 27

Stifel Nicolaus Remains a Buy on Glaukos (GKOS)

TIPRANKS
·
Jan 26

Glaukos President and COO Joseph E. Gilliam Reports Disposal of Common Shares

Reuters
·
Jan 24

Glaukos Advances Phase 3 Glaucoma Implant Trial, Keeping GKOS in Focus for Investors

TIPRANKS
·
Jan 22

Glaukos CEO Thomas William Burns Reports Disposal of Common Shares

Reuters
·
Jan 21

Glaukos Corporation to Release Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 20

Stock Track | Glaukos Soars 5.04% Intraday on Wells Fargo's Buy Rating and $122 Price Target

Stock Track
·
Jan 15

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS)

TIPRANKS
·
Jan 15

Wells Fargo Sticks to Its Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Jan 15

Glaukos falls -8.5%

TIPRANKS
·
Jan 14

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
Jan 14

Analysts Are Bullish on Top Healthcare Stocks: Glaukos (GKOS), Rapid Micro Biosystems (RPID)

TIPRANKS
·
Jan 14

Glaukos Shares Fall 13.8% Premarket After Co Releases Q4 Prelim Sales

THOMSON REUTERS
·
Jan 14

Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga_recent_news
·
Jan 14

Glaukos Price Target Maintained With a $125.00/Share by Needham

Dow Jones
·
Jan 14

Stock Track | Glaukos Plunges 13.82% in Pre-market as iDose Sales Growth Disappoints

Stock Track
·
Jan 14

Stock Track | Glaukos Plunges 12% as iDose Sales Growth Disappoints Despite Reaffirmed 2026 Guidance

Stock Track
·
Jan 14